Megumi Inoue, Tetsuro Ogawa, Hiroshi Tamura, Yosuke Hagiwara, Yuki Saito, Darren Abbanat, . . . Patricia Ibarra de Palacios. (2018). Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMegumi Inoue, et al. Safety, Tolerability and Immunogenicity of the ExPEC4V (JNJ-63871860) Vaccine for Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease: A Phase 1, Randomized, Double-blind, Placebo-controlled Study in Healthy Japanese Participants. Taylor & Francis Group, 2018.
MLA (9th ed.) CitationMegumi Inoue, et al. Safety, Tolerability and Immunogenicity of the ExPEC4V (JNJ-63871860) Vaccine for Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease: A Phase 1, Randomized, Double-blind, Placebo-controlled Study in Healthy Japanese Participants. Taylor & Francis Group, 2018.